Physician profile
Daryl R Burrows
NPI 1619191863
$29,250.31
in general payments reported to CMS, 2019-2025
32 companies · $513 in 2025
The $513 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $11K · 2021: $1,126 · 2022: $927 · 2023: $853 · 2024: $440 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,806.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $25,650.56 | 2019-2025 | Evenity, Prolia, Tepezza |
| Dexcom, INC. | $1,109.13 | 2019-2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $330.92 | 2019-2025 | Ozempic, Rybelsus, Saxenda |
| Radius Health, INC. | $244.16 | 2019-2025 | Tymlos |
| Abbott Laboratories | $219.87 | 2019-2025 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $185.65 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $150.83 | 2022-2025 | |
| Abbvie INC. | $145.09 | 2019-2025 | |
| Tandem Diabetes Care, INC. | $126.51 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Astrazeneca Pharmaceuticals LP | $119.59 | 2019-2023 | Farxiga |
| Insulet Corporation | $111.72 | 2019-2023 | Omnipod |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.45 | 2020-2023 | Jardiance |
| Beta Bionics, INC. | $79.13 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Medtronic, INC. | $78.70 | 2024-2025 | Minimed 780g |
| Antares Pharma, INC. | $73.15 | 2022-2025 | Xyosted, Nocdurna, Tlando |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recordati_rare_diseases_inc. | $67.64 | 2020-2025 | Isturisa |
| Janssen Pharmaceuticals, INC | $55.03 | 2019-2020 | |
| Lilly USA, LLC | $54.68 | 2022-2024 | Jardiance, Baqsimi, Lyumjev |
| Esperion Therapeutics, INC. | $48.38 | 2021-2023 | Nexletol |
| Merck Sharp & Dohme LLC | $42.44 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.73 | 2023-2025 | |
| Corcept Therapeutics | $34.06 | 2019-2024 | Korlym |
| Valeritas, INC. | $29.81 | 2019 | |
| Ascendis Pharma Endocrinology INC | $24.41 | 2023 | |
| Ultragenyx Pharmaceutical INC. | $23.35 | 2021 | |
| Alexion Pharmaceuticals, INC. | $21.15 | 2025 | Strensiq |
| Ascensia Diabetes Care US INC. | $19.90 | 2020 | |
| Sequel Med Tech, LLC | $18.83 | 2025 | Twiist |
| Amarin Pharma, INC. | $18.20 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $13.88 | 2019 | |
| Medtronic Minimed, INC. | $12.70 | 2019 | |
| Shire North American Group INC | $12.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daryl Burrows listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.